Back

Lessons from REDUCE-IT: How will the results impact practice?

30 August 2020 (19:05 - 19:20)
Organised by:
Congress Presentation Part of: Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides Lipid-Lowering Agents Open Access ESC Congress 2020

About the speaker

Photo
Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

4 More presentations in this session

Presentation thumbnail
Introduction.
Professor P. Libby (Boston, US)
Video
Presentation thumbnail
The residual risk challenge in CVD: How important are triglycerides?
Professor U. Landmesser (Berlin, DE)
Video
Presentation thumbnail
Non-LDL in CV risk management & guidelines: What are the opportunities?
Professor K. Ray (London, GB)
Video
Presentation thumbnail
Discussion.
Professor P. Libby (Boston, US)
Video

Access the full session

Session thumbnail
Novel opportunities tackling residual cardiovascular Risk: The evolving role of triglycerides
Video

The Event

Event poster

ESC Congress 2020

30 August 2020 19:05 CET
You may be interested in
thumbnail
Congress Session
New frontiers in ASCVD risk reduction: integrating icosapent ethyl in clinical practice
26 August 2022
thumbnail
Webinar
Reducing risk in the post-MI patient
6 September 2023
thumbnail
Congress Presentation
Cardiovascular risk reduction & hypertriglyceridemia: integrating the evidence
29 August 2025
thumbnail
Congress Presentation
REDUCE-IT: outcomes by baseline statin type
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources